🧬 Shekhar Mitra - InnoPreneur & P&G - Part 3 | The First Big Innovation Center in Asia | The Whole Work of Leadership | Noticeability Driven Through Technology | Developing Emotional Drivers

The Biotech Startups Podcast

https://www.linkedin.com/in/shekhar-mitra-ph-d-4b427b47/

16:03

Learn about the differences between Alzheimer's and dementia, and how Alzheimer's disease progresses. We talk about why catching the disease early can make a big difference. Dr. Sharon Cohen and Dr. Yaakov Stern walk us through the stages of Alzheimer's disease, from when there are no symptoms to when memory issues start to show. They explain the stages of Alzheimer’s and how it develops over time. We also hear from Kelly, who explains her personal experiences and concerns about developing Alzheimer’s, and what she does about it. For links to resources and information covered in this series, visit our website at HealthUnmuted.com/resources What did you think of this episode? We’d love to hear from you. Please visit healthunmuted.com/feedback to let us know! Rethinking Alzheimer’s Disease was made possible with support from Eisai Inc. [00:00:00] Introduction [00:03:10] What's the difference between Alzheimer's disease and dementia? [00:07:04] When does Alzheimer’s begin to develop? [00:09:08] What is Mild Cognitive Impairment (MCI)? [00:10:36] What is subjective cognitive decline? [00:11:59] What is preclinical Alzheimer's disease? [00:13:13] Why is it important to detect Alzheimer’s disease early? Disclaimer: The content provided in this podcast is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast. Reliance on any information provided by this podcast or its guests is solely at your own risk. ©2024 Mission Based Media Ltd • April 2024 • AD-M2059…

год назад 34:55

MP3•Главная эпизода

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 3 of 4.

My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Procter & Gamble and current President and Founder of InnoPreneur, a strategic advisory firm that enables development of innovation capabilities, ideation, and organizational development for Fortune 500 corporations and new ventures.

Prior to InnoPreneur, Shekhar spent 29 years at Procter & Gamble where he worked his way up from staff scientist to Senior Vice President of Global Innovation and Chief of Innovation, becoming a part of P&G's top leadership team and a member of the CEO's Global Leadership Council. Shekhar’s time at P&G paints a successful entrepreneurial road map for those looking to learn, grow, and innovate within large corporations. Post retirement from P&G, Shekhar spent several years as a board member and strategic adviser to several Fortune 500 corporations, new ventures, and private equity companies developing transformational new ideas, business strategies, and organization capabilities to drive growth. With over 50 patents awarded in different fields, Shekhar’s an expert with an exceptional track record in creating and developing game changing technology platforms and formulating disruptive innovation strategies, whose extensive background in R&D offers unique insights that listeners can benefit from.

Join us this week and hear about:

The challenges of building the first big innovation center in Asia
Giving people a chance to impress you and what the whole work of leadership is
Building emotional bonds and noticeability in your customer base
The importance and impact of developing emotional drivers in your customers
And much more!

Please enjoy my conversation with Shekhar Mitra.

Timestamps

00:28 Intro

01:52 Episode starts, working as Director of R&D in Asia for Procter & Gamble and the challenge of building the first big innovation center in Asia

05:20 Bringing the developments and innovations learned in China to the global markets

08:54 No one does it alone, and the sacrifices others had to make to support the risks they needed to take to ultimately succeed

11:50 The whole work of leadership is giving people a chance to impress you, supporting them but also hold them responsible for their mistakes

14:55 Needing a game-changing breakthrough every two to three years to maintain a prestige brand

19:36 P&G’s cyclohexane perfume innovation and having your product’s noticeability driven through technology

28:13 Developing emotional drivers with your customers through things like scent, their pets, and the comfort of their babies

33:49 Outro

Find Our Guest, Shekhar Mitra, at this link:

Find Our Host, Jon Chee, at these links:

https://www.linkedin.com/in/jonchee

https://www.excedr.com

Social & Website

LinkedIn: https://www.linkedin.com/company/excedr/

Youtube: https://www.youtube.com/@excedr

Instagram: https://www.instagram.com/excedr_inc

Twitter: https://twitter.com/ExcedrInc

Facebook: https://www.facebook.com/excedr

TikTok: https://www.tiktok.com/@excedr

Podcast Website: https://www.thebiotechstartupspodcast.com/

Enriched Notes:

Topics Mentioned:

Cyclodextrin https://en.wikipedia.org/wiki/Cyclodextrin

Lab Equipment for Biochemistry Research https://www.excedr.com/blog/lab-equipment-list-for-biochemistry-research

What is DNA Extraction?

https://www.excedr.com/blog/what-is-dna-extraction

What Types of Equipment is Used in Molecular Biology Research?

https://www.excedr.com/blog/what-type-of-equipment-is-used-in-molecular-biology-research

People Mentioned:

John Pepper https://en.wikipedia.org/wiki/John_E._Pepper_Jr.

Gordon Brunner https://www.linkedin.com/in/gordon-brunner-b38b36278/

Steve Hicks https://www.linkedin.com/in/stephenjhicks/

Sumit Bahsin https://www.linkedin.com/in/sumit-bhasin-5970989/

The Biotech Startups Podcast is handcrafted by our friends over at: fame.so

128 эпизодов

#Science #Biology #Business #Jon Chee #Biotech Startups #Biotech #Startup #Excedr #Life Sciences #Entrepreneur #Founders #Culture

The Biotech Startups Podcast

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 3 | The First Big Innovation Center in Asia | The Whole Work of Leadership | Noticeability Driven Through Technology | Developing Emotional Drivers

The Biotech Startups Podcast

published год назад

MP3•Главная эпизода

Part 3 of 4.

Join us this week and hear about:

The challenges of building the first big innovation center in Asia
Giving people a chance to impress you and what the whole work of leadership is
Building emotional bonds and noticeability in your customer base
The importance and impact of developing emotional drivers in your customers
And much more!

Please enjoy my conversation with Shekhar Mitra.

Timestamps

00:28 Intro

01:52 Episode starts, working as Director of R&D in Asia for Procter & Gamble and the challenge of building the first big innovation center in Asia

05:20 Bringing the developments and innovations learned in China to the global markets

08:54 No one does it alone, and the sacrifices others had to make to support the risks they needed to take to ultimately succeed

11:50 The whole work of leadership is giving people a chance to impress you, supporting them but also hold them responsible for their mistakes

14:55 Needing a game-changing breakthrough every two to three years to maintain a prestige brand

19:36 P&G’s cyclohexane perfume innovation and having your product’s noticeability driven through technology

28:13 Developing emotional drivers with your customers through things like scent, their pets, and the comfort of their babies

33:49 Outro

Find Our Guest, Shekhar Mitra, at this link:

https://www.linkedin.com/in/shekhar-mitra-ph-d-4b427b47/

Find Our Host, Jon Chee, at these links:

https://www.linkedin.com/in/jonchee

https://www.excedr.com

Social & Website

LinkedIn: https://www.linkedin.com/company/excedr/

Youtube: https://www.youtube.com/@excedr

Instagram: https://www.instagram.com/excedr_inc

Twitter: https://twitter.com/ExcedrInc

Facebook: https://www.facebook.com/excedr

TikTok: https://www.tiktok.com/@excedr

Podcast Website: https://www.thebiotechstartupspodcast.com/

Enriched Notes:

Topics Mentioned:

Cyclodextrin https://en.wikipedia.org/wiki/Cyclodextrin

Lab Equipment for Biochemistry Research https://www.excedr.com/blog/lab-equipment-list-for-biochemistry-research

What is DNA Extraction?

https://www.excedr.com/blog/what-is-dna-extraction

What Types of Equipment is Used in Molecular Biology Research?

https://www.excedr.com/blog/what-type-of-equipment-is-used-in-molecular-biology-research

People Mentioned:

John Pepper https://en.wikipedia.org/wiki/John_E._Pepper_Jr.

Gordon Brunner https://www.linkedin.com/in/gordon-brunner-b38b36278/

Steve Hicks https://www.linkedin.com/in/stephenjhicks/

Sumit Bahsin https://www.linkedin.com/in/sumit-bhasin-5970989/

The Biotech Startups Podcast is handcrafted by our friends over at: fame.so

128 эпизодов

#Science #Biology #Business #Jon Chee #Biotech Startups #Biotech #Startup #Excedr #Life Sciences #Entrepreneur #Founders #Culture

Все серии

The Biotech Startups Podcast

1
🧬 Stavros Papadopoulos: Transforming Data Management (Part 4/4) 34:08

3 дня назад34:08

34:08

🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . "In life sciences, time is more important for all stakeholders. Because if you're working in life sciences, you have an obligation. You have a moral obligation to be very efficient, if not optimal." In this final part of our conversation with Stavros , founder and CEO of TileDB, we explore the challenges and opportunities in transforming data management within the life sciences sector. Stavros discusses how smaller organizations often lag behind in adopting innovative solutions due to lack of awareness and reliance on existing tools, while larger companies like big pharma are more proactive in seeking advanced technologies. Stavros highlights the importance of behavioral change in technology adoption, emphasizing that companies should focus on their core competencies rather than building infrastructure. He draws parallels with AWS, which revolutionized server management by allowing companies to focus on their products rather than infrastructure. The conversation also touches on the moral obligation of life sciences companies to optimize efficiency, given the impact on human lives. Key topics covered: Challenges for Smaller Organizations: Overcoming barriers to adopting new technologies due to limited awareness and resources. Adoption Contrast: Big pharma vs. smaller organizations in embracing innovative solutions. Behavioral Change in Technology Adoption: The need for mindset shifts in leveraging external solutions. Efficiency in Life Sciences: The moral obligation to optimize time and resources in the sector. Parallels with AWS: How outsourcing infrastructure can accelerate innovation and focus on core competencies. If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Stavros Papadopoulos, at these links: LinkedIn: https://www.linkedin.com/in/stavrospap/ Website: https://www.linkedin.com/company/tiledb-inc/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Resources & Mentions: Crossing the Chasm by Geoffrey Moore: http://soloway.pbworks.com/w/file/fetch/46715502/Crossing-The-Chasm.pdf Azure (Microsoft's cloud computing service): https://azure.microsoft.com/en-gb/ Companies & people mentioned: MIT: https://www.mit.edu/ TileDB: https://tiledb.com/ AWS (Amazon Web Services): https://aws.amazon.com/ Millipore Sigma: https://www.sigmaaldrich.com/ Y Combinator: https://www.ycombinator.com/ PlayStation: https://www.playstation.com/ Jake Glanville: https://www.linkedin.com/in/jacobglanville Jeff Bezos: https://x.com/jeffbezos?lang=en Timestamps: 00:00 Intro 01:10 Discussion on working with smaller companies and scalable products 02:16 Stavros explains how TileDB can replace solution architects 05:07 Discussion on freeing up resources for high ROI initiatives 06:22 Stavros highlights the difficulty of behavioral changes in adopting new technologies 10:16 Jon reflects on the importance of valuing time in life sciences 12:57 Introduction of TileDB's new product, Carrara 18:16 Discussion on meeting users where they are with Carrara 20:06 Stavros shares his vision for TileDB's future adoption 23:30 Jon expresses enthusiasm for TileDB's impact on health outcomes 26:15 Shoutouts to supporters and team members 29:32 Advice to his 21-year-old self 30:30 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Stavros Papadopoulos: Scaling TileDB & Revolutionizing Data Infrastructure (Part 3/4) 36:00

6 дней назад36:00

36:00

🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . "We're wasting money. You're wasting money as an organization, like, hundreds of millions of dollars that can save you that money easily. But you have to start reasoning a little bit differently." In this third part of our conversation with Stavros Papadopoulos , founder and CEO of TileDB, we delve into the company's ambitious vision to revolutionize data management in the life sciences sector. Stavros shares the journey of TileDB from its inception as a highly technical solution to its current position as a potential game-changer in how organizations handle diverse data types. He discusses the challenges of selling innovative solutions to large pharmaceutical companies and the stark contrast in adoption between big pharma and smaller organizations. Stavros, with his background as a technologist from MIT, details the early days of TileDB, emphasizing the intense focus on technological innovation and performance optimization. He describes the company's evolution from a small team of highly skilled engineers to securing significant funding and attracting major customers in the life sciences sector. Throughout the conversation, Stavros highlights the philosophical aspect of TileDB's mission, stressing its potential impact on accelerating scientific discovery and ultimately saving lives. Key topics covered: TileDB's Vision for a Multimodal Database: Replacing fragmented data management systems Challenges in Selling Innovative Solutions: Large pharmaceutical companies as a target market The Contrast Between Big Pharma & Smaller Organizations: Adopting new technologies The Philosophical Drive Behind TileDB's Mission: Accelerating scientific discovery Organizational Inertia & Decision-Making Complexities: Enterprise software adoption If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Stavros Papadopoulos, at these links: LinkedIn: https://www.linkedin.com/in/stavrospap/ Website: https://www.linkedin.com/company/tiledb-inc/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Resources & Mentions: Crossing the Chasm by Geoffrey Moore: http://soloway.pbworks.com/w/file/fetch/46715502/Crossing-The-Chasm.pdf Intel's Parallel Computing Lab: https://faculty.cc.gatech.edu/~echow/ipcc/ Intel Science and Technology Center for Big Data at MIT CSAIL: http://hammer.csail.mit.edu/ Hong Kong University of Science and Technology: https://hkust.edu.hk/ AWS (Amazon Web Services): https://aws.amazon.com/ Azure (Microsoft's cloud computing service): https://azure.microsoft.com/en-gb/ Companies & people mentioned: Intel: https://www.intel.com/ MIT: https://www.mit.edu/ TileDB: https://tiledb.com/ Broad Institute: https://www.broadinstitute.org/ Silicon Valley Bank: https://www.svb.com/ Browne Consulting: https://browneconsulting.com/ Snowflake: https://www.snowflake.com/ Databricks: https://www.databricks.com/ Seth Shelnutt: https://www.linkedin.com/in/seth-shelnutt/ Dimitris Papadias: https://cse.hkust.edu.hk/admin/people/faculty/profile/dimitris Yufei Tao: https://www.linkedin.com/in/yufei-tao-328b0b251/?originalSubdomain=hk Timestamps: 00:00 Intro 01:18 Early days of TileDB and its mission 06:36 Building a high-performance team and securing early customers 09:22 Discussing the vision behind TileDB 12:11 The problem of data infrastructure complexity 16:26 TileDB as a multimodal database for discovery 19:27 The inefficiency of in-house database solutions in pharmaceuticals 23:09 Overcoming organizational inertia in adopting new technologies 28:20 The necessity of TileDB for drug discovery 29:48 Differences in working with smaller vs. larger organizations 33:21 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬Stavros Papadopoulos: How Serendipity Sparked TileDB's Startup Journey (Part 2/4) 42:22

10 дней назад42:22

42:22

🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . "Serendipity plays a big role, but you need to chase it, man. You need to [chase it] and you need to perform. You need to deliver [on] your end of the deal." In part two of our conversation with Stavros Papadopoulos , founder of TileDB, we delve into his journey from academia to entrepreneurship. Stavros shares his experiences at MIT and Intel, and the serendipitous events that led to the founding of his company. He details the transition from working on cutting-edge database systems to identifying a market need in the life sciences sector, particularly in handling complex genomic data. Stavros's background in computer science and his work at the intersection of Intel and MIT uniquely positioned him to tackle the challenges of building a new type of database system. His journey highlights the importance of proactivity, networking, and being prepared for unexpected opportunities. He also shares valuable insights on the realities of starting a database company, including the significant funding requirements and the necessity of continuous learning. Key topics covered: Transition from academia to entrepreneurship: Seizing opportunities at MIT and Intel Developing TileDB: C reating a novel database system for complex data types Fundraising journey: From angel investors to venture capital Challenges of starting a database company: High costs and talent requirements Importance of mentorship and building win-win relationships in tech entrepreneurship: Key strategies for success If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Stavros Papadopoulos, at these links: LinkedIn: https://www.linkedin.com/in/stavrospap/ Website: https://www.linkedin.com/company/tiledb-inc/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Mentions: Resources & Articles: Disciplined Entrepreneurship: 24 Steps to a Successful Startup by Bill Aulet: https://www.d-eship.com/ Zero to IPO by Frederic Kerrest: https://www.linkedin.com/pulse/book-day-zero-ipo-frederic-kerrest-summary-mircea-ioan-soit-kvspe/ TileDB database technology: https://cloud.tiledb.com/academy/what-is-tiledb/ Genomics DB (precursor to TileDB): https://www.tiledb.com/blog/population-genomics-data-with-tiledb MIT Technology Licensing Office: https://tlo.mit.edu/ Broad Institute's VCF (Variant Call Format): https://www.broadinstitute.org/publications/broad12186 Rady Children's Institute for Genomic Medicine (RCIGM): https://radygenomics.org/begin-ngs-newborn-sequencing/ UK Biobank: https://www.ukbiobank.ac.uk/ Companies & People: Intel: https://www.intel.com/ MIT: https://www.mit.edu/ TileDB: https://tiledb.com/ Broad Institute: https://www.broadinstitute.org/ Nexus Venture Partners: https://nexusvp.com/ Sam Madden: https://www.linkedin.com/in/samuel-madden-8ba0835/ Frederic Kerrest: https://www.linkedin.com/in/fkerrest/ Timestamps: 00:00 Intro 01:24 Transitioning from Hong Kong to MIT/Intel 11:30 The importance of proactivity and hustle in seizing opportunities 20:59 Working on database systems at MIT/Intel 29:08 The serendipitous encounter that led to starting TileDB 32:16 Developing TileDB: A database for non-tabular data and machine learning 35:30 Solving scalability issues for the Broad Institute 36:55 Raising initial funding and spinning out TileDB from MIT/Intel 37:26 Challenges of starting a database business 38:15 Structuring TileDB's launch as a win-win for all stakeholders 39:47 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Stavros Papadopoulos: A Journey in Computer Science & Data Management (Part 1/4) 54:24

13 дней назад54:24

54:24

accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . "If you are capable of acquiring knowledge, of applying the knowledge, and you like it, you can succeed. It doesn't matter what it is." In this episode of The Biotech Startups Podcast, we delve into Stavros Papadopoulos ' transformative journey from Greece to Hong Kong, exploring his experiences as a PhD student at the Hong Kong University of Science and Technology. Stavros shares how a chance encounter on a bus and his professor's last-minute recommendation led him to pursue his doctorate in Hong Kong, a decision that would shape his career and personal life. Stavros describes Hong Kong as the "best city in the world," highlighting the perfect balance between intense academic rigor and vibrant city life. He explains how the university's unique environment, with students working late into the night and a campus integrated into the natural landscape, fostered both hard work and adventure. Stavros also touches on his research focus, which evolved from spatiotemporal databases to data security and cryptography, and how he learned valuable skills that continue to shape his career to this day. Key topics covered: The Power of Mentorship: How guidance from family, professors, and peers influenced Stavros' academic journey Choosing Hong Kong: Balancing academic excellence with quality of life in selecting a PhD program HKUST Experience: Rigorous academics, supportive professors, and a vibrant student community Research Evolution: Transitioning from spatiotemporal databases to data security and cryptography Work-Life Balance: Maintaining high academic performance while enjoying Hong Kong's unique offerings If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Stavros Papadopoulos, at these links: LinkedIn: https://www.linkedin.com/in/stavrospap/ Website: https://www.linkedin.com/company/tiledb-inc/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Resources & Mentions: Spatiotemporal Databases: https://en.wikipedia.org/wiki/Spatiotemporal_database Data Security and Cryptography in Database Management: https://datastackshow.com/podcast/what-is-a-universal-database-featuring-stavros-papadopoulos-of-tiledb-inc/ MIT CSAIL: https://www.csail.mit.edu/ TileDB Universal Database: https://docs.tiledb.com/cloud/concepts/universal-data-management Genomics Data Management: https://tiledb.com/blog/population-genomics-is-a-data-management-problem LiDAR Data Processing: https://tiledb.com/blog/analyzing-lidar-and-sar-data-with-capella-space-and-tiledb Big Data in Telecommunications: https://startups.epam.com/blog/big-data-analytics-for-telecommunications Venture Capital Funding for Tech Startups: https://www.investopedia.com/terms/v/venturecapital.asp Companies & people mentioned: Hong Kong University of Science and Technology: https://hkust.edu.hk/ TileDB: https://tiledb.com/ HKUST: https://iau-hesd.net/university/hong-kong-university-science-and-technology MIT: https://www.mit.edu/ Intel: https://www.intel.com/ Dimitris Papadias: https://www.linkedin.com/in/dimitris-papadias-8429b423a Yanis Manolopoulos: https://www.linkedin.com/in/yannis-manolopoulos-47989514/?originalSubdomain=gr Timestamps: 00:00 Intro 01:47 Early Inclination Towards Learning and Competitiveness 03:52 Grandmother's Gift of First Computer 07:23 Cousin's Advice: A Plan for Computer Science and Silicon Valley 12:23 Mentorship and Guidance 17:18 University Experience and Disappointment 21:34 Tips for Getting into Top US Schools 27:36 Serendipitous Encounter on a Bus: Hong Kong Beckons 36:10 Balancing Hard Work and Enjoyment 42:24 Hong Kong's Unique Appeal and University Life 48:20 Research Focus: Spatiotemporal Databases and Data Security 53:06 Data Security and Cryptographic Techniques 53:36 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Becky Beattie: Scaling LaunchBio & Democratizing Biotech Entrepreneurship (Part 2/2) 1:06:16

17 дней назад1:06:16

1:06:16

🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . "If I'm not building something, then I'm probably not going to be doing it for long. That's the fun part." In part two of our conversation with Becky Beattie , CEO of LaunchBio, we explore her journey scaling a national nonprofit dedicated to supporting early-stage life science founders. Becky shares how she transitioned from BioLabs to LaunchBio, initially joining what she jokingly calls "a lunch club," and eventually stepping into leadership during the pandemic. She details LaunchBio's evolution from local programming to a national organization connecting biotech entrepreneurs with critical resources and capital. Becky's background in both science and real estate uniquely positioned her to understand the challenges of biotech startups, particularly around shared lab spaces and ecosystem development. Her leadership at LaunchBio has focused on creating targeted connections between founders and investors while expanding into new markets and launching initiatives for underrepresented entrepreneurs. Key topics covered: Building LaunchBio: From "lunch club" to national nonprofit supporting early-stage life science founders Navigating leadership challenges: Taking the CEO role during a pandemic and pivoting to virtual programming Creating Investor Connect: Developing curated matchmaking between startups and appropriate VCs Expanding biotech ecosystems: Building thriving life science hubs in emerging markets like Dallas Launching HiveBio: A new accelerator program for underrepresented founders in the life sciences If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Becky Beattie, at these links: LinkedIn: https://www.linkedin.com/in/rebecca-beattie-68927a9/ Website: https://launchbio.org/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Resources & Mentions: Resources & articles mentioned: Investor Connect https://launchbio.org/programs/investor-connect/ NextGen VC Podcast https://launchbio.org/nextgen-vc-podcast/ Invest in Cures Forum https://launchbio.org/programs/invest-in-cures/ EDA Build to Scale Grant https://www.eda.gov/funding/programs/build-to-scale UCSD Gene Therapy Initiative https://genetherapy.ucsd.edu/ Companies & people mentioned: LaunchBio: https://launchbio.org/ HiveBio: https://www.hivebio.io/ BioLabs: https://www.biolabs.io/ Pegasus Park https://pegasuspark.com/ Phase Three: https://phasethreere.com/ Biocom: https://www.biocom.org/ Wilson Sonsini: https://www.wsgr.com/ Connect: https://connect.org/ Susie Harborth https://www.linkedin.com/in/sharborth/ Johannes Fruehauf https://www.linkedin.com/in/johannesfruehauf/ Joan Rose https://www.linkedin.com/in/joansrose/ Kelly Huang https://www.linkedin.com/in/kellychuang/ Caroline Okun https://www.linkedin.com/in/brainsarepretty/ Meredith Martindale https://www.linkedin.com/in/meredithmartindale/ Melissa Schmidt https://www.linkedin.com/in/melissakschmidt/ Sasha Farina https://www.linkedin.com/in/sasha-farina/ Nirav Shah https://www.linkedin.com/in/shahnirav321/ Timestamps: 00:00 Intro 02:09 Returning to life sciences and meeting Susie Harborth 04:47 Joining BioLabs and the shared lab space movement 07:33 The origins of LaunchBio as a "lunch club" 12:47 Challenges of shared lab spaces and building biotech ecosystems 20:01 Joining LaunchBio and focusing on early-stage life science founders 25:11 Transitioning LaunchBio during COVID and scaling nationally 31:22 Taking on the CEO role at LaunchBio during the pandemic 37:51 Launching Investor Connect to strategically match startups with VCs 40:17 Building biotech ecosystems in Dallas and other emerging markets 45:17 Launching HiveBio, an accelerator for underrepresented founders 51:20 The Invest in Cures Forum and rare disease funding initiatives 55:54 Closing reflections and shoutouts 01:03:24 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Becky Beattie: From Rural Beginnings to Building a National Biotech Network (Part 1) 1:03:23

20 дней назад1:03:23

1:03:23

🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . “If you’re not enjoying what you’re doing or having fun, why are you doing it? Combine that with hard work and you can achieve cool things.” In part one of our conversation with Becky Beattie , CEO of LaunchBio, we trace her unconventional path from rural San Jose pig farmer to biotech ecosystem builder. Becky shares how her early entrepreneurial grit, scientific curiosity, and business acumen converged to shape her career – including surviving a life-altering spinal injury and pioneering shared lab spaces. Becky holds dual degrees in molecular biology and business from the University of Colorado Boulder. Before leading LaunchBio, she honed her skills in life science sales (SeraCare, Eppendorf), strategic marketing (Comprendia), and real estate innovation (ROC Shared Workspace). Key topics covered: Growing up in 4-H raising pigs: Early lessons in economics and grit Mixing science & business: Blending molecular biology training with business strategy at CU Boulder Cold-calling challenges: Cutting teeth in biotech sales at SeraCare Life Sciences Pivoting through crisis: How a spinal cord injury reshaped career priorities Building the shared lab space movement: Pre-WeWork innovation for life sciences If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Becky Beattie, at these links: LinkedIn: https://www.linkedin.com/in/rebecca-beattie-68927a9/ Website: https://launchbio.org/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Resources & Mentions: Resources & articles mentioned: LaunchBio’s Larger Than Life Program: https://www.launchbio.org/programs/larger-than-life Founder Circle Peer Advisory Forums: https://launchbio.org/programs/founders-circle/ SBIR Grants: https://www.excedr.com/blog/sbir-grants-guide STTR Grants: https://www.excedr.com/blog/sttr-grants-guide Build to Scale Grant Program: https://www.eda.gov/funding-opportunies UCSD Gene Therapy Initiative: https://healthsciences.ucsd.edu/innovation Companies & people mentioned: LaunchBio: https://launchbio.org/ Eppendorf: https://www.eppendorf.com/ BioLabs: https://www.biolabs.io/ Heinrich Netheler: https://corporate.eppendorf.com/en/company/history/founders/ Hans Hinz: https://corporate.eppendorf.com/en/company/history/founders/ Timestamps: 00:00 Intro 03:15 Becky's early life and entrepreneurial experiences 05:55 College years and combining science with business 11:45 First job in biotech sales at SeraCare Life Sciences 16:44 Transition to Eppendorf and capital equipment sales 24:50 Balancing career and family after having children 31:03 Spinal cord injury and two-year recovery period 36:22 Return to work in real estate with ROC shared workspace 42:26 Lessons learned from sales and relationship-building 46:52 The importance of marketing and business strategy 51:23 Reflections on career pivots and personal growth 55:05 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Dr. Kate Yen: Scaling a Biotech, Running Lean, & Utilizing Translational Biology (Part 2) 52:19

24 дня назад52:19

52:19

🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners . “I didn’t set out to be an entrepreneur, but when I couldn’t find a company doing what I believed in, I built my own.” In part two of our conversation with Kate Yen , Founder and CEO of Auron Therapeutics, we explore her journey from leading a novel cancer therapy program at Agios to founding her own biotech company. Kate shares insights into drug development, clinical trials, and the business of biotech, highlighting the importance of translational biology, strategic partnerships, and lean operations in building a successful biotech startup. Kate earned her Ph.D. in Biological Chemistry from UCLA, where she also completed her postdoc. Before Auron, she held roles at Merck and as a UCLA professor before joining Agios Pharmaceuticals, where she led the IDH translational research team behind two FDA-approved IDH mutant inhibitors and co-led the discovery of vorasidenib, a promising glioma therapy now in clinical development. Key topics covered: Navigating clinical trials from discovery to FDA approval with a biomarker-driven approach The importance of translational biology and how Auron integrates it from day one Building a lean biotech startup , from early fundraising to assembling a high-impact team Securing big pharma partnerships in a challenging biotech market Leveraging AI and machine learning to map cancer biology and identify new drug targets If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Youtube: https://www.youtube.com/@excedr Website: https://www.thebiotechstartupspodcast.com/ Find our guest, Kate Yen, at these links: LinkedIn: https://www.linkedin.com/in/kate-yen-448b22108/ Website: https://www.aurontx.com/ Find our host, Jon Chee, at these links: LinkedIn: https://www.linkedin.com/in/jonchee Learn more about Excedr LinkedIn: https://www.linkedin.com/company/excedr/ Website: https://www.excedr.com Resources & articles mentioned: The Role of Translational Biology in Drug Development: https://www.sciencedirect.com/science/article/abs/pii/S1359644612004060 Navigating Clinical Trials: https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process Building & Running a Lean Biotech Startup: https://www.lablaunch.org/post/building-a-lean-biotech-startup Biotech Startup Fundraising Options: https://www.excedr.com/resources/biotech-startup-funding-options Biotech Partnerships - How Partnerships Support R&D: https://www.excedr.com/blog/how-biotech-partnerships-support-research How to Bootstrap Your Biotech Startup & Scale: https://www.excedr.com/resources/how-to-bootstrap-biotech-startup How to Choose the Right CRO for Biotech: https://www.excedr.com/blog/contract-research-organizations How Much Does Lab Space Cost? https://www.excedr.com/blog/how-much-does-lab-space-cost Top VC Firms for Biotech in 2024 - Supporting Innovation & Growth: https://www.excedr.com/blog/top-vc-firms-for-biotech 50 Biotech Seed & Angel Investors to Check Out in 2025: https://www.excedr.com/blog/biotech-seed-and-angel-investors Companies & people mentioned: Auron Therapeutics: https://www.aurontx.com/ Merck: https://www.merck.com/ Agios Pharmaceuticals: https://www.agios.com/ UCLA: https://www.ucla.edu/ Princeton University: https://www.princeton.edu/ Charles Sawyers: https://en.wikipedia.org/wiki/Charles_Sawyers Lew Cantley: https://en.wikipedia.org/wiki/Lewis_C._Cantley David Schenkein: https://www.linkedin.com/in/david-schenkein-md-45342476/ Mike Carey: https://www.uclahealth.org/cancer/members/michael-carey Ruben Shaw: https://www.linkedin.com/in/reuben-shaw-1b8611109/ Timestamps: 00:00 Intro 02:10 Kate Yen’s transition into leadership at Agios 05:39 Navigating clinical trials and biomarker-driven decision-making 10:29 The importance of translational biology in drug development 14:19 Taking the leap to start Auron Therapeutics 18:36 Raising early funding and building a lean biotech startup 26:41 Leveraging AI and machine learning in cancer drug discovery 30:58 Running a biotech startup with a sustainable and transparent culture 41:07 Fundraising strategies to expanding Auron’s platform beyond oncology 47:08 Closing questions for Kate 49:35 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Kate Yen - Part 1 | From Academia to Biotech Leader | Translating Research into Cancer Therapies | Early Days at Merck & Agios 52:15

27 дней назад52:15

52:15

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 1 of 2 : Our guest today is Kate Yen, Founder and CEO of Auron Therapeutics. Auron Therapeutics leverages cutting-edge science and AI-powered analysis to develop next-generation cancer therapies by mapping key drivers of tumorigenesis. Kate earned her Ph.D. in Biological Chemistry from UCLA, where she also completed her postdoc. She held roles at Merck and as a UCLA professor before joining Agios Pharmaceuticals, where she led the IDH translational research team behind two FDA-approved IDH mutant inhibitors and co-led the discovery of vorasidenib, a promising glioma therapy now in clinical development. With deep expertise in preclinical and clinical research, a proven track record in advancing breakthrough therapies, and a passion for oncology, Kate’s journey and insights are invaluable. In this episode, you'll hear about: Kate Yen’s journey from aspiring physician to PhD researcher at UCLA How her postdoc in Charles Sawyers’ lab sparked her passion for translational research Transitioning from academia to industry and learning drug discovery at Merck Taking the leap to join Agios Pharmaceuticals and leading the IDH program The role of collaboration in biotech, from academia to CRO partnerships If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening. Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Find Our Guest, Kate Yen, at these links: https://www.linkedin.com/in/kate-yen-448b22108/ https://www.aurontx.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: Auron Therapeutics: https://www.aurontx.com/ Merck: https://www.merck.com/ Agios Pharmaceuticals: https://www.agios.com/ UCLA: https://www.ucla.edu/ Princeton University: https://www.princeton.edu/ Biotech Startup Fundraising: https://www.excedr.com/resources/biotech-startup-funding-options Biotech Accelerators: https://www.excedr.com/resources/biotech-accelerators Biotech Incubators: https://www.excedr.com/resources/biotech-incubators Top VC Firms for Biotech: https://www.excedr.com/blog/top-vc-firms-for-biotech 50 Biotech Seed & Angel Investors: https://www.excedr.com/blog/biotech-seed-and-angel-investors Guide to Choosing a CRO: https://www.excedr.com/blog/contract-research-organizations Guide to Choosing a CMO: https://www.excedr.com/blog/contract-manufacturing-organizations People Mentioned: Charles Sawyers: https://en.wikipedia.org/wiki/Charles_Sawyers Lew Cantley: https://en.wikipedia.org/wiki/Lewis_C._Cantley David Schenkein: https://www.linkedin.com/in/david-schenkein-md-45342476/ Mike Carey: https://www.uclahealth.org/cancer/members/michael-carey Timestamps: 00:00 Intro 03:01 Kate Yen’s background and Auron Therapeutics’ mission 04:40 Early influences and passion for research 06:27 Choosing academia over medicine, attending UCLA grad school 13:11 Postdoc with Charles Sawyers and translational research 16:58 Transitioning to industry and joining Merck 24:44 Learning drug discovery and pharma culture at Merck 32:32 Taking the leap to Agios Pharmaceuticals 37:42 Leading the IDH program and cancer research 44:43 Collaborating with academic labs and CROs 50:28 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Oguzhan Atay - Part 2 | From Immigrant to Biotech Innovator | Battling Deportation with Nobel Laureate Support | Building a $140M Prenatal Testing Empire 1:05:37

4 weeks назад1:05:37

1:05:37

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 2 of 2 : Our guest today is Oguzhan Atay, Co-founder & CEO of BillionToOne. BillionToOne is a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. They work to improve disease detection by counting molecules with their proprietary molecular counting platform. They place patients at the forefront of everything they do and are currently applying their proprietary technology to non-invasive prenatal screening and liquid biopsy. Oguzhan holds a Ph.D. from Stanford in Systems Biology, where he implemented machine learning algorithms and mathematical models to solve specific problems in cellular biology and developed a data-driven mathematical framework to simplify the analysis of complex biological networks. He also has a degree in Molecular Biology from Princeton, as well as minors in Computer Science, Physics, and Applied Mathematics. Oguzhan not only combines deep technical expertise with visionary leadership, but he also has an incredibly inspirational immigrant journey, which makes this series a must-listen for first-time founders, scientists, and industry leaders alike. In this episode, you'll hear about: Oguzhan's journey from Turkey to Stanford BillionToOne's origin, including Y Combinator's role and initial funding challenges The company's innovative prenatal testing approach Expansion into oncology with blood tests for therapy selection and monitoring Oguzhan's personal struggles with immigration issues while starting the company and the support of his mentors If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening! Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Find Our Guest, Oguzhan Atay, at these links: https://www.linkedin.com/in/oatay/ https://billiontoone.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: BillionToOne https://billiontoone.com/ Y Combinator https://www.ycombinator.com/ Common Mistakes Biotechs Make & How to Avoid Them https://www.excedr.com/blog/common-business-mistakes How to Fund an R&D Startup https://www.excedr.com/resources/rd-startup-funding-first-steps Guide to the Venture Capitalist Decision https://www.excedr.com/resources/guide-to-the-venture-capitalist-decision-making-process People Mentioned: David Tsao https://www.linkedin.com/in/davidtsao/ Jim Collins https://en.wikipedia.org/wiki/James_C._Collins Timestamps: 00:00 - Intro 02:28 - The origin of BillionToOne and early challenges 06:48 - Y Combinator's role and initial funding struggles 12:24 - Meeting co-founders and pivoting based on market needs 17:17 - Realizing the importance of the problem in the United States 24:11 - Building physical infrastructure and scaling operations 32:04 - Company culture, hiring philosophy, and growth strategy 38:55 - Expanding into oncology and future product lines 46:40 - Plans for going public and becoming a generational company 53:42 - Shoutouts to supporters and overcoming immigration challenges 59:34 - Advice to his 21-year-old self: keeping an open mind 01:02:51 - Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Oguzhan Atay - Part 1 | From Small-Town Turkey to Stanford PhD | Solving Cell Cycle Mysteries | Building a Biotech During a Global Pandemic 1:01:28

5 weeks назад1:01:28

1:01:28

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 1 of 2 : Our guest today is Oguzhan Atay, Co-founder & CEO of BillionToOne. BillionToOne is a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. They work to improve disease detection by counting molecules with their proprietary molecular counting platform. They place patients at the forefront of everything they do and are currently applying their proprietary technology to non-invasive prenatal screening and liquid biopsy. Oguzhan holds a Ph.D. from Stanford in Systems Biology, where he implemented machine learning algorithms and mathematical models to solve specific problems in cellular biology and developed a data-driven mathematical framework to simplify the analysis of complex biological networks. He also has a degree in Molecular Biology from Princeton, as well as minors in Computer Science, Physics, and Applied Mathematics. Oguzhan not only combines deep technical expertise with visionary leadership, but he also has an incredibly inspirational immigrant journey, which makes this series a must-listen for first-time founders, scientists, and industry leaders alike. In this episode, you'll hear about: Oguzhan's upbringing in a small Turkish town His early passion for science, deciding to become a scientist at just 10 years old Oguzhan's experience in Turkey's rigorous education system His transition to studying at Princeton Oguzhan's PhD journey at Stanford If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening! Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Find Our Guest, Oguzhan Atay, at these links: https://www.linkedin.com/in/oatay/ https://billiontoone.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: Princeton https://www.princeton.edu/ Stanford https://www.stanford.edu/ BillionToOne https://billiontoone.com/ Common Mistakes Biotechs Make & How to Avoid Them https://www.excedr.com/blog/common-business-mistakes How to Fund an R&D Startup https://www.excedr.com/resources/rd-startup-funding-first-steps Guide to the Venture Capitalist Decision https://www.excedr.com/resources/guide-to-the-venture-capitalist-decision-making-process People Mentioned: Jan Skotheim https://www.linkedin.com/in/jan-skotheim-5157a426a/ Daniel Fisher https://www.linkedin.com/in/daniel-fisher-5466812a/ Jacques Fresco https://www.asbmb.org/asbmb-today/people/082222/in-memoriam-jacques-fresco Max Delbruck https://en.wikipedia.org/wiki/Max_Delbr%C3%BCck Linus Pauling https://en.wikipedia.org/wiki/Linus_Pauling J. Robert Oppenheimer https://en.wikipedia.org/wiki/J._Robert_Oppenheimer Timestamps: 00:00 - Intro 05:41 - Oguzhan's upbringing in Turkey and his parents' emphasis on education 10:22 - Competitive nature of the Turkish education system 15:18 - Oguzhan's decision to attend Princeton for undergraduate studies 21:28 - Integrated science program at Princeton and interdisciplinary approach 26:57 - Oguzhan's experience at the University of Oxford 32:20 - Choosing Stanford for PhD studies 38:21 - Oguzhan's PhD research at Stanford in cell cycle control 43:24 - The importance of resilience in scientific research and entrepreneurship 48:54 - BillionToOne's challenges and creative solutions during the COVID-19 pandemic 55:47 - How overcoming challenges led to unprecedented growth for BillionToOne 59:41 - Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Parag Shah - Part 2 | Scaling a Multi-Billion Dollar Life Sciences Fund | Culture, Capital & Entrepreneurship | The K2 HealthVentures Story 1:05:09

5 weeks назад1:05:09

1:05:09

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 2 of 2 : Our guest today is Parag Shah, CEO and Founding Managing Director of K2 HealthVentures. K2 HealthVentures is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. Committed to making a broader impact, K2 also donates a percentage of its profits to support underserved areas in healthcare. Before founding K2, Parag was Senior Managing Director & Group Head of the Life Sciences practice at Hercules Capital, where he led the fund’s public offering and managed over $2 billion in investments. His deep expertise in life science and healthcare financing was further shaped through key leadership roles at Comerica, Imperial Bank, and BankBoston.Parag’s academic background includes a Masters in Environmental Policy & Planning and a Bachelors in Molecular Biology from MIT, where he conducted research at the Whitehead Institute. With 25+ years of experience at the intersection of science and finance, Parag brings invaluable insights for first-time founders, investors, scientists, and industry leaders navigating the complexities of biotech funding. In this episode, you'll hear about: How Parag scaled Hercules Capital into a multi-billion-dollar life sciences fund The challenges of building a strong company culture in investment firms Why evergreen capital structures can be a game-changer for biotech startups The founding story of K2 HealthVentures and its mission-driven approach How balancing work, family, and entrepreneurship leads to long-term success If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening! Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Find Our Guest, Parag Shah, at these links: https://www.linkedin.com/in/paragshah333/ https://k2hv.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: K2 HealthVentures: https://www.k2healthventures.com/ Hercules Capital: https://www.htgc.com/ Cooley LLP: https://www.cooley.com/ Life Science Cares: https://lifesciencecares.org/ Debt vs. Equity Financing for Biotech Startups: https://www.excedr.com/resources/debt-equity-options-funding-startup Biotech Startup Fundraising: https://www.excedr.com/resources/biotech-startup-funding-options Biotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-support People Mentioned: Roy Liu: https://www.linkedin.com/in/roy-liu-36a35/ Anup Arora: https://www.linkedin.com/in/anup-arora-368ba81/ Meghan FitzGerald: https://www.linkedin.com/in/meghanmfitzgerald/ John Hale: https://www.linkedin.com/in/john-hale-770158b/ Timestamps: 00:00 Intro 01:54 Early days at Hercules and the challenge of biotech debt 06:14 Scaling Hercules, taking it public, and leadership lessons 11:34 Public vs. private investment funds: Key trade-offs and pressures 19:18 Leaving Hercules, taking a break, and redefining priorities 25:35 Avoiding burnout: Balancing work, family, and entrepreneurship 29:04 How time and capital constraints drive better decision-making 33:52 Founding K2 HealthVentures and reshaping biotech venture debt 39:01 Evergreen investment structure and why it benefits startups 46:59 The importance of co-founders, team culture, and shared vision 53:32 Scaling K2, launching a foundation, and investing with purpose 01:02:24 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Parag Shah - Part 1 | Rethinking Biotech Startup Funding | Building Smarter Capital Strategies | Risk, Reward & Leadership in Investing 47:53

6 weeks назад47:53

47:53

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 1 of 2 : Our guest today is Parag Shah, CEO and Founding Managing Director of K2 HealthVentures. K2 HealthVentures is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. Committed to making a broader impact, K2 also donates a percentage of its profits to support underserved areas in healthcare. Before founding K2, Parag was Senior Managing Director & Group Head of the Life Sciences practice at Hercules Capital, where he led the fund’s public offering and managed over $2 billion in investments. His deep expertise in life science and healthcare financing was further shaped through key leadership roles at Comerica, Imperial Bank, and BankBoston.Parag’s academic background includes a Masters in Environmental Policy & Planning and a Bachelors in Molecular Biology from MIT, where he conducted research at the Whitehead Institute. With 25+ years of experience at the intersection of science and finance, Parag brings invaluable insights for first-time founders, investors, scientists, and industry leaders navigating the complexities of biotech funding. In this episode, you'll hear about: How Parag’s NYC upbringing shaped his leadership and risk-taking mindset His transition from molecular biology to finance and investing Key lessons from his early career in credit and venture lending How he helped shape biotech venture credit and redefine startup financing When to use debt vs. equity in life sciences fundraising If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening! Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4 Find Our Guest, Parag Shah, at these links: https://www.linkedin.com/in/paragshah333/ https://k2hv.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: K2 HealthVentures: https://www.k2healthventures.com/ Hercules Capital: https://www.htgc.com/ BankBoston (now part of Bank of America): https://en.wikipedia.org/wiki/BankBoston Imperial Bank (acquired by Comerica): https://www.comerica.com/ Venture Debt in Biotech: https://www.fiercebiotech.com/biotech/rise-venture-debt-and-when-biotechs-should-and-shouldnt-use-it Equity vs. Debt Financing: https://www.excedr.com/resources/debt-equity-options-funding-startup Biotech Startup Fundraising: https://www.excedr.com/resources/biotech-startup-funding-options Risk-Taking & Leadership in Startups: Biotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-support Scaling Biotech Companies: https://www.linkedin.com/pulse/scaling-up-overcoming-multifaceted-challenges-growing-rami-levin-njoqe/ People Mentioned: Larry Suskind: https://dusp.mit.edu/people/lawrence-susskind John Ehrenfeld: https://www.linkedin.com/in/johnehrenfeld/ Timestamps: 00:00 Intro 02:59 Parag’s background and early career in finance 06:24 Growing up in NYC and how his parents influenced his mindset 09:42 The impact of education and key mentors in shaping his path 15:11 Transitioning from science to finance, why he left the lab 19:56 Lessons from Bank Boston and entering the world of credit investing 24:32 Moving to Argentina and unexpected entry into banking 29:56 Joining Imperial Bank and the challenges of building biotech venture credit 36:37 Understanding risk-taking and decision-making in biotech financing 42:52 When startups should use debt vs. equity and how venture debt fits into biotech funding 46:02 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Jason C. Foster - Part 2 | Manufacturing Brighter Futures | From Richmond to London: Building a Biotech Empire | Culture Eats Strategy for Breakfast 1:05:39

6 weeks назад1:05:39

1:05:39

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 2 of 2 : My guest today is Jason C. Foster, CEO and Executive Director of Ori Biotech. Ori is revolutionizing Cell and Gene Therapy manufacturing through the development of its proprietary platform, IRO®. By automating and standardizing Cell and Gene Therapy manufacturing, Ori and IRO® offer scientists the tools they need to streamline development and support widespread patient access to life-saving treatments. Jason's experience prior to Ori includes more than 20 years of life science leadership in operations, sales, marketing, technology, and investing, during which he developed deep expertise in commercial strategy and a thorough understanding of healthcare markets across the UK, US, and EU. In this episode, you'll hear about: Jason Foster's journey from Virginia to London The critical role of culture in company success Ori Biotech's mission to increase accessibility of cell therapies by developing scalable manufacturing solutions Challenges in commercializing cell therapies and the need to consider commercial viability alongside safety and efficacy Jason's leadership insights, including the concept of being a "trusted advisor" and the importance of transparency in team building If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening! Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Find Our Guest, Jason C. Foster, at these links: https://www.linkedin.com/in/jasoncfoster/ https://oribiotech.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: Ori Biotech https://oribiotech.com/ How to Spin Out of Academia https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startup How VC-Backed Startups Win When They Lease https://www.excedr.com/blog/how-vc-backed-startups-win-when-they-lease Marketing & Sales Strategies for Startups https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs People Mentioned: Farlan Veraitch https://www.linkedin.com/in/farlan-singh-veraitch-a677112/ Reed Hastings https://www.linkedin.com/in/reedhastings/ Dan Pink https://www.linkedin.com/in/danielpink/ Timestamps: 00:00 - Intro 05:21 - Early days of expanding the business in Europe 10:37 - Reflections on entrepreneurship within a large organization 15:44 - The importance of culture in building a successful company 20:35 - Jason's journey to founding Ori Biotech 27:22 - Building Ori Biotech from the ground up 33:35 - The challenges and potential of cell therapy 39:51 - Ori Biotech's approach to go-to-market strategy 46:09 - The importance of being a trusted advisor to clients 51:10 - Hiring for cultural fit and building a strong team 55:17 - Future plans for Ori Biotech 57:59 - Shoutouts to mentors and supporters 1:00:05 - Advice to his 21-year-old self 1:02:48 - Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Jason C. Foster - Part 1 | From Paper Routes to Pharma | Navigating the Dot-Com Bubble | Building a $1B Addiction Medicine Business in 4 Years 53:22

7 weeks назад53:22

53:22

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique referral link here : refer.excedr.com/ZTHETY . Part 1 of 2 : My guest today is Jason C. Foster, CEO and Executive Director of Ori Biotech. Ori is revolutionizing Cell and Gene Therapy manufacturing through the development of its proprietary platform, IRO®. By automating and standardizing Cell and Gene Therapy manufacturing, Ori and IRO® offer scientists the tools they need to streamline development and support widespread patient access to life-saving treatments. Jason's experience prior to Ori includes more than 20 years of life science leadership in operations, sales, marketing, technology, and investing, during which he developed deep expertise in commercial strategy and a thorough understanding of healthcare markets across the UK, US, and EU. In this episode, you'll hear about: Jason Foster's early entrepreneurship, from paper routes to creative ventures His transformative time at Columbia Business School, learning valuable lessons about decision-making and international perspectives Jason's entry into healthcare through Merck-Medco His experience growing a small pharmaceutical company from 5 to 400 employees, focusing on addiction medicine The decision to move his family to London to start the European branch of the business If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening! Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994 Find Our Guest, Jason Foster, at these links: https://www.linkedin.com/in/jasoncfoster/ https://oribiotech.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/jonchee https://www.excedr.com Excedr Socials & Website LinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned: University of Virginia https://www.virginia.edu/ Columbia University https://www.columbia.edu/ Merck https://en.wikipedia.org/wiki/Merck_%26_Co . Medco https://en.wikipedia.org/wiki/Medco_Health_Solutions How to Spin Out of Academia https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startup How VC-Backed Startups Win When They Lease https://www.excedr.com/blog/how-vc-backed-startups-win-when-they-lease Marketing & Sales Strategies for Startups https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs People Mentioned: Larry Sabato https://en.wikipedia.org/wiki/Larry_Sabato Emma Walmsley https://www.linkedin.com/in/emmawalmsleygsk/?originalSubdomain=uk Timestamps: 00:00 Intro 04:51 Early years and entrepreneurial experiences 10:10 College decision process and time at the University of Virginia 18:05 Jason's experience in Washington D.C. and introduction to healthcare policy 20:57 Jason's decision to pursue an MBA at Columbia University 25:04 Memorable lessons from Columbia MBA program 30:47 Jason's transition to the private sector and joining Merck Medco 36:41 Insights on effective sales techniques in the pharmaceutical industry 43:19 Jason's career progression after Columbia and joining Medco Health Solutions 51:02 Jason's move to a small pharmaceutical company in Richmond, Virginia 54:59 Outro The Biotech Startups Podcast is handcrafted by our friends over at: fame.so…

The Biotech Startups Podcast

1
🧬 Rafael Rosengarten - Part 4 | Lessons in Scaling a Biotech Startup | Using AI to Transform Cancer Diagnostics | The Genialis Supermodel & krasID 40:45

7 weeks назад40:45